Daily Market Report – December 23, 2025
At 8:30 AM New York time (2:30 PM CET), the US Bureau of Economic Analysis released the first estimate of GDP for the third quarter of 2025. The American economy grew surprisingly strong at an annualized rate of +4.3%. At the same time, the US Department of Commerce released data for October on durable goods (−2.2%). Due to the government shutdown, both datasets are likely distorted. At 10:00 AM (4:00 PM CET), the Conference Board released consumer confidence at 89.1 points.
In summary: The US economy grew strongly due to robust consumer demand, high government spending, and a favorable trade balance. However, companies are cautious about investments and hiring new workers. The fifth consecutive decline in consumer confidence is a warning sign.
The stock markets remained subdued in pre-Christmas trading. One stock stood out: Novo Nordisk NVO announced on December 23, 2025, that the US FDA has approved a tablet form of Wegovy. The stock rose over 7 percent in the US - in hopes that more people will seek oral medications for weight reduction.